Mandeg, Michell T.

HRN: 11-48-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2022
CEFUROXIME 500MG (TAB)
07/31/2022
08/07/2022
ORAL
500mg/tab
BID
S/P NSVD; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: